President and Chief Science Officer Zohrab Bostanian founded RDI in 2008, foreseeing the need for an independent IVD trial specialist. As R&D scientist and associate director of product validation with Siemens for 12 years, Zohrab designed and developed dozens of new IVD products. He holds degrees from California State University, Los Angeles and conducted cancer biology research at UCLA’s Weintraub Cancer Center.
CEO Conall Arora brings vast experience in building best-in-class businesses to his role at RDI. His career includes roles at Soros, Goldman Sachs, and five years as a distressed private equity investor at MatlinPatterson, in addition to success as investor turning around two bankrupt companies now worth $2.6 billion today. Conall holds degrees in pre-med and economics from Columbia University, New York. With a network of independent physicians as his family and friends, he brings a special perspective to his role.